Search Bar & Filters
Found 11 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the impact and burden of three skin conditions moderate or severe alopecia areata, non-segmental vitiligo, and moderate to severe hidradenitis suppurativa. The study includes adolescents and adults and aims to understand how these conditions affect quality of life and daily functioning in a large global population. This is an observational study where participants with each condition will have a single visit for data collection following routine clinical practice. No experimental treatments are given instead, the study gathers information during this one visit to assess disease characteristics and impact. During the visit, participants will complete questionnaires and clinical assessments specific to their condition. These include tools measuring symptom impact, hair loss severity, skin depigmentation, and quality of life related to each disease. This helps researchers better understand the real-world burden of these conditions. Participation involves only this one visit, with no long-term follow-up or additional procedures.
Actively Recruiting
Researchers are studying adult patients with unresectable or metastatic HER2-low and HER2-ultralow expressing breast cancer who have either received prior chemotherapy in the metastatic setting or have hormone receptor-positive disease not suitable for endocrine therapy. The study aims to observe the real-world use and effects of Trastuzumab deruxtecan T-DXd and conventional chemotherapy in these populations. This observational study collects data without administering any study drugs directly, focusing on patient characteristics, treatment patterns, and safety. Participants will be grouped into those receiving T-DXd according to approved medical guidelines and those treated with conventional chemotherapy, including drugs like capecitabine and paclitaxel. The study records treatment details and the management of any adverse reactions, with Group 2 patients contributing baseline data on conventional chemotherapy. Treatments are given as part of routine clinical care, following the Summary of Product Characteristics, without experimental interventions. During the study, participants treatment courses will be tracked for up to approximately 37 months. Researchers will evaluate the time to next treatment, treatment discontinuation, safety events, and patients impressions of treatment tolerability and quality of life. Data collection includes physician reports, patient diaries, and quality of life questionnaires. This long-term monitoring helps to understand treatment patterns and patient experiences in real-world settings.
Actively Recruiting
Researchers are conducting an observational study called the France PCI Registry to monitor and improve care in interventional cardiology, focusing on procedures like coronary angiography and angioplasty. This national observatory started in 2014 in the Centre Val de Loire region and aims to build a reliable database of interventional cardiology activities. The study is led by the Club Rgional des Angioplasticiens de la rgion Centre and seeks to optimize patient care times, especially for those with STEMI a type of heart attack. The study collects data fully integrated with usual coronary activity reporting software across multiple catheterization labs. It tracks interventional cardiology activities over a year and monitors secondary outcomes such as improving care times for STEMI patients within 24 hours. There are no investigational drugs or treatments administered, as this is an observational study gathering information from routine clinical practice. Participants who have undergone coronary angiograms or angioplasty are involved through data collection during their usual care. The study regularly evaluates data quality to maintain an exhaustive and reliable database. Researchers measure the volume and quality of interventional cardiology procedures and how quickly STEMI patients receive care. Participation lasts as long as the data collection period, with ongoing observation but no additional interventions or treatments.
Actively Recruiting
Researchers are studying the impact of Ziwig Endotest4, a medical device that identifies endometriosis from a saliva sample using advanced sequencing and algorithms. This non-invasive test aims to reduce diagnostic delays and guide treatment strategies for women with suspected endometriosis. The study focuses on how the Endotest results affect patients quality of life, emotional experiences, coping strategies, and care pathways, areas not yet fully documented. Participants are women aged 18 to 43 who have been prescribed the Endotest. The study is observational and involves completing validated self-report questionnaires, such as EHP 56 and RAND-36, at the start, six months, and twelve months. Clinical data will also be collected from medical records to track the impact of the Endotest on patient care, including tests, treatments, and procedures like laparoscopy, as well as on assisted reproductive technology journeys. During the study, participants will complete questionnaires at baseline, six months, and twelve months to assess quality of life, anxiety levels, pelvic sensitivity, and adaptation strategies. The research team will monitor the patients care pathways and compare outcomes based on Endotest results across different countries. The study aims to provide valuable, generalizable data over an average follow-up period of one year to inform both clinicians and patients.
Actively Recruiting
Bronchiectasis is a chronic lung condition where parts of the airways are permanently widened, causing mucus buildup, infections, and ongoing inflammation. This study evaluates the long-term use of the SIMEOX medical device at home, combined with remote physiotherapy, to improve quality of life and reduce lung flare-ups in adults with non-cystic fibrosis bronchiectasis. The research compares this approach to enhanced standard care including remote physiotherapy alone. Participants will be randomly assigned to either standard care with remote physiotherapy or to use the SIMEOX device daily at home alongside remote physiotherapy. Remote physiotherapy sessions occur once a month for the first three months and then every three months. The study spans an average of 24 months to assess the effects of adding the SIMEOX device to usual care. During the study, participants will complete quality of life questionnaires and undergo lung function tests at 6, 12, and 24 months. The main outcomes measured include the yearly rate of lung exacerbations and changes in quality of life scores. Researchers will also track hospitalizations, treatment compliance, adverse events, and lung function changes. The long follow-up aims to evaluate the sustained impact of the device and physiotherapy on participants respiratory health.
Actively Recruiting
Researchers are collecting biological samples to improve diagnosis and treatment of rare neuroimmune disorders affecting the central and peripheral nervous system. These disorders include Paraneoplastic Neurological Syndromes PNS and Autoimmune Encephalitis AE, which involve immune system activity. The study aims to support faster and more accurate diagnosis, benefiting patients with these conditions by enhancing future treatment approaches. Participants diagnosed with PNS or AE will have biological samples collected once, including blood and possibly cerebrospinal fluid if available. Blood samples will be used to obtain serum, buffy coat, plasma, and peripheral blood mononuclear cells. If cerebrospinal fluid is drawn for diagnosis, any remaining sample will be stored. This collection will occur during a single visit, and samples will be stored for up to 10 years. During the study, participants will provide consent and undergo sample collection only once. Researchers will monitor the blood samples and cerebrospinal fluid biocollection over 10 years. The study emphasizes scientific collaboration and ongoing research to improve understanding and treatment of these neurological disorders. Participation duration focuses on the collection and long-term storage of biological samples.
Actively Recruiting
Researchers are studying patients who have been treated for hematological malignancies such as leukemia, lymphoma, and multiple myeloma. The study aims to evaluate whether an early return-to-work after cancer consultation can improve the rate and quality of patients returning to work. This prospective, randomized, multicenter study focuses on supportive care, as returning to work is linked to better quality of life outcomes including financial stability and social engagement. Participants will be divided into two groups one receiving the specialized return-to-work consultation and the other receiving standard care without this consultation. The consultation is conducted by a specialist in occupational pathology and may include support from a psychologist, nurse, or social worker. It lasts about one hour and addresses medical, social, and psychological factors affecting return to work, offering guidance and solutions tailored to each participants situation. During the study, participants return-to-work status will be monitored over 12 months. The research team will assess various outcomes including return-to-work rates, changes in professional status, quality of life, anxiety and depression levels, and self-efficacy related to returning to work. Evaluations will be done at baseline and at 3, 6, and 12 months. Participants will also self-assess the benefit of the consultation at 3 and 6 months. The study will continue through March 2028.
Actively Recruiting
Researchers are conducting a multinational, prospective, proof of concept phase II randomized clinical trial to assess the safety and effectiveness of Remote Ischemic PreConditioning RIPC in patients with lymphoma who are receiving anthracycline chemotherapy. This study uses a double-blinded, sham-controlled design to compare RIPC with a simulated procedure in patients undergoing at least five chemotherapy cycles. Participants will be randomly assigned to receive either weekly RIPC or a sham procedure during their chemotherapy treatment. Each session involves four cycles of 5 minutes of blood pressure cuff inflation followed by 5 minutes of deflation on the arm, with RIPC inflating to 200 mmHg to stop blood flow and sham inflating to a low pressure that does not stop blood flow. Baseline cardiac magnetic resonance imaging CMR and blood tests will be performed before chemotherapy, with follow-up CMR and blood tests after the third and last chemotherapy cycles, and again nine weeks after finishing chemotherapy. Patients will be monitored for clinical events up to 42 months after treatment. Throughout the study, participants will undergo multiple assessments including CMR scans, blood tests measuring cardiac markers, and questionnaires evaluating quality of life related to hematological malignancy and cardiomyopathy. Researchers will track the rate of cardiotoxicity induced by anthracyclines, changes in heart function, tumor regression, hospitalizations for heart failure, and quality of life changes. The total follow-up period for clinical outcomes is expected to be about 36 months on average, with the study concluding when the last patient completes their final evaluations.
Actively Recruiting
Chronic obstructive pulmonary disease COPD causes breathing difficulties, less physical activity, muscle weakening, and lower quality of life. Pulmonary rehabilitation helps but is often hard to access and maintain long-term. This study tests an augmented reality virtual coach designed to support exercise practice for adults with COPD by providing real-time visual and audio guidance while keeping users connected to their real environment. Participants will take part in a single experimental session using an augmented reality headset with a virtual coach. After completing baseline questionnaires and receiving an introduction to the headset, they will perform a guided exercise session lasting about 20 minutes. Exercises include calf raises, sit-to-stand movements, and stretching, with the virtual coach offering standardized instructions and feedback. The study will assess how acceptable this technology is by using questionnaires before and after the session and by gathering user experiences through focus group discussions. During the study visit, participants will complete surveys about their experience and the technologys acceptability. Researchers will analyze responses from the Technology Acceptance Model 3 questionnaire and explore user feedback from group discussions. The main outcome is the global acceptability score of the augmented reality coach immediately after the session. The study aims to identify factors that may help or limit the future use of this technology in pulmonary rehabilitation for COPD patients.
Actively Recruiting
Chronic obstructive pulmonary disease COPD is a serious lung condition that reduces exercise tolerance and quality of life. Pulmonary rehabilitation helps improve breathing, exercise capacity, and overall well-being, but many patients face barriers such as travel difficulties and limited rehab center availability. This research compares a home-based telerehabilitation program to traditional center-based pulmonary rehabilitation to assess their effects on exercise endurance in adults with COPD. The study randomly assigns participants aged 45 to 80 with stable COPD to either a home-based or center-based rehabilitation group. Both groups complete 24 sessions over eight weeks, including endurance training on a cycle ergometer, muscle strengthening, balance exercises, and therapeutic education tailored to individual needs. The home-based group uses equipment like a cycle ergometer, pulse oximeter, activity tracker, and a tablet app for guidance and remote monitoring, while the center-based group attends sessions at rehabilitation centers. Both groups have initial and final in-person assessments. Participants will undergo assessments before and after the program, including exercise endurance tests on a cycle ergometer. Researchers will monitor adherence, physical activity, quality of life, cognitive function, and health events over one year. Regular support and education aim to ensure safety and effectiveness. The total involvement includes rehabilitation sessions, assessments, and follow-up evaluations, with safety measures in place to minimize exercise-related risks.
1-10 of 11
1